These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22850479)

  • 1. New antithrombotic agents for the treatment of coronary artery disease: overview.
    Schneider DJ
    Coron Artery Dis; 2012 Sep; 23(6):367. PubMed ID: 22850479
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology of antithrombotic drugs in coronary artery disease.
    Fauler J
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of race and gender on antithrombotic therapy.
    Capodanno D; Angiolillo DJ
    Thromb Haemost; 2010 Sep; 104(3):471-84. PubMed ID: 20664898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances and perspectives of antithrombotic therapy for coronary artery diseases in China].
    Li Y; Zhao R; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Sep; 47(9):683-688. PubMed ID: 31550834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges of antiplatelet therapy in patients who require anticoagulation.
    Henkel DM; Holmes DR
    J Invasive Cardiol; 2009 Apr; 21(4):186-9. PubMed ID: 19342758
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotic therapy for stable coronary artery disease: the difficult quest for the holy balance.
    Danchin N; Puymirat E; Schiele F
    Eur Heart J; 2016 Jan; 37(4):409-11. PubMed ID: 26508161
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithrombotic agents in coronary bypass surgery in The Netherlands].
    Galema TW; Verheugt FW
    Ned Tijdschr Geneeskd; 1990 Aug; 134(34):1632-6. PubMed ID: 2215703
    [No Abstract]   [Full Text] [Related]  

  • 9. Combining antiplatelet and anticoagulant therapies.
    Holmes DR; Kereiakes DJ; Kleiman NS; Moliterno DJ; Patti G; Grines CL
    J Am Coll Cardiol; 2009 Jul; 54(2):95-109. PubMed ID: 19573725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing antithrombotic strategies in patients with concomitant indications for warfarin undergoing coronary artery stenting.
    Zinn A; Feit F
    Am J Cardiol; 2009 Sep; 104(5 Suppl):49C-54C. PubMed ID: 19695362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and antiplatelet therapy in stable coronary artery disease: A multicenter survey.
    Kopin D; Jones WS; Klein A; Barnes GD
    Thromb Res; 2019 Aug; 180():25-27. PubMed ID: 31170568
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimized combination of antiplatelet treatment and anticoagulation for percutaneous coronary intervention: the final word is not out yet!
    Gruberg L; Beyar R
    J Invasive Cardiol; 2002 May; 14(5):251-3. PubMed ID: 11983946
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antithrombotic therapy in acute coronary syndrome].
    Chazov EI; Panchenko EP
    Ter Arkh; 2000; 72(3):65-75. PubMed ID: 10776658
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition.
    Roe MT; Kikano G; Miller CD; Hoekstra JW
    Postgrad Med; 2008 Jul; 120(2):67-78. PubMed ID: 18654071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effect of locally available brands of clopidogrel on platelet aggregation in patients with coronary artery disease.
    Khan SB; Hameedullah ; Noor L; Hafeezullah M; Awan ZA; ud Din S
    J Ayub Med Coll Abbottabad; 2010; 22(1):115-7. PubMed ID: 21409920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Cannon CP; Rhee KE; Califf RM; Boden WE; Hirsch AT; Alberts MJ; Cable G; Shao M; Ohman EM; Steg PG; Eagle KA; Bhatt DL;
    Am J Cardiol; 2010 Feb; 105(4):445-52. PubMed ID: 20152237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ; van Hattum ES
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract]   [Full Text] [Related]  

  • 18. The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts.
    D'Agate DJ; Patel S; Coppola JT; Ambrose JA
    J Invasive Cardiol; 2004 Sep; 16(9):500-3. PubMed ID: 15353833
    [No Abstract]   [Full Text] [Related]  

  • 19. Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulation.
    Rubboli A; Colletta M; Di Pasquale G
    Am Heart J; 2005 Feb; 149(2):E1. PubMed ID: 15846242
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in cardiology.
    Menown IA; Shand JA
    Future Cardiol; 2010 Jan; 6(1):11-7. PubMed ID: 20014984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.